The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Karyopharm Therapeutics
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Geron; Incyte; Novartis; Ryvu Therapeutics; Sierra Oncology; Taiho Pharmaceutical; Takeda; TG Therapeutics
Research Funding - ALX Oncology; Astex Pharmaceuticals; Incyte; TG Therapeutics
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Celgene; Incyte; Ryvu Therapeutics; Sierra Oncology; TG Therapeutics
Health-related quality of life (HRQoL) in patients (pts) with myelodysplastic syndromes (MDS) in the Connect Myeloid Disease Registry.
 
Dennis A. Revicki
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene
 
David L. Grinblatt
Honoraria - Alexion Pharmaceuticals
Consulting or Advisory Role - Celgene
Speakers' Bureau - Alexion Pharmaceuticals; celgene
 
Rami S. Komrokji
Stock and Other Ownership Interests - Abbvie
Consulting or Advisory Role - Abbvie; Acceleron Pharma; Bristol-Myers Squibb; Geron; Jazz Pharmaceuticals; Novartis
Speakers' Bureau - Agios; Bristol-Myers Squibb; Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Agios; Bristol-Myers Squibb; Jazz Pharmaceuticals
 
Guillermo Garcia-Manero
Honoraria - Abbvie; Acceleron Pharma; Astex Pharmaceuticals; Celgene; Helsinn Healthcare
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Bristol-Myers Squibb; Celgene; Helsinn Therapeutics; Jazz Pharmaceuticals
Research Funding - Abbvie; Amphivena; Astex Pharmaceuticals; Bristol-Myers Squibb; celgene; H3 Biomedicine; Helsinn Therapeutics; Merck; Novartis; Onconova Therapeutics
 
Michael R. Savona
No Relationships to Disclose
 
Bart Scott
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Celgene; Novartis
Speakers' Bureau - Alexion Pharmaceuticals; Celgene; Jazz Pharmaceuticals; Novartis
Research Funding - Celgene (Inst)
 
Mikkael A. Sekeres
Consulting or Advisory Role - Celgene; Millennium; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Takeda (Inst)
 
E. Dawn Flick
Employment - Bristol-Myers Squibb
Leadership - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Adeola Y. Makinde
No Relationships to Disclose
 
Pavel Kiselev
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Chrystal U. Louis
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene; crispr therapeutics
Patents, Royalties, Other Intellectual Property - Cell Medica
 
Melissa Nifenecker
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Irene S. DeGutis
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Christopher R. Cogle
Consulting or Advisory Role - Bristol-Myers Squibb